A Comparison of Cyclosporine 0.05% Ophthalmic Emulsion Versus Vehicle in Chinese Patients with Moderate to Severe Dry Eye Disease: An Eight-Week, Multicenter, Randomized, Double-Blind, Parallel-Group Trial

医学 畏光 随机对照试验 视力 不利影响 眼科 人造眼泪 相伴的 眼病 视力模糊 外科 内科学
作者
Minjie Chen,Lan Gong,Xinghuai Sun,Hanping Xie,Yueqin Zhang,Liu-he Zou,Jia Qu,Yumin Li,Jia He
出处
期刊:Journal of Ocular Pharmacology and Therapeutics [Mary Ann Liebert, Inc.]
卷期号:26 (4): 361-366 被引量:59
标识
DOI:10.1089/jop.2009.0145
摘要

PURPOSE: The goals of this study were to compare the efficacy and safety profile of topical cyclosporine 0.05% versus vehicle in Chinese patients with moderate to severe dry eye disease. METHODS: In this multicenter, randomized, double-blind, vehicle-controlled, parallel-group study, 233 dry eye patients were allocated to receive either cyclosporine 0.05% or vehicle twice daily for 8 weeks. Primary outcome was the difference between groups, in total score of 4 symptoms and 4 signs change from baseline at weeks 2, 4, and 8. Changes in symptoms (ocular dryness, foreign body sensation, photophobia and burning) and signs (conjunctival hyperemia, Schirmer test, tear Break-up time (BUT), and corneal punctate fluorescein staining) at weeks 2, 4, and 8 as well as frequency of administration of concomitant artificial tears, were considered as secondary outcomes. The safety profile was evaluated by examining adverse events, changes in visual acuity, and ocular tolerance. RESULTS: Greater improvements of the total score were seen in cyclosporine 0.05% group than in the vehicle group at all follow-up times (P < 0.01). Improvements in ocular dryness at week 8 (P = 0.040) and foreign body sensation during weeks 4 and 8 (P < 0.020) were significantly greater with cyclosporine. In addition, compared with the vehicle, cyclosporine significantly improved 2 objective dry eye disease signs: corneal staining at weeks 4 (P = 0.025) and 8 (P = 0.050) and the Schirmer test at week 4 (P = 0.035). However, no between-group difference approached statistical significance in photophobia, burning, BUT value, conjunctival hyperemia and frequency of administration of concomitant artificial tears at any follow-up times (P > 0.05).The cumulative frequency of adverse events did not significantly differ between the groups (P = 0.519), which were 11.21% and 8.55%, respectively. There were no patients who experienced reduced visual acuity. CONCLUSION: Cyclosporine 0.05% ophthalmic emulsion is an effective and safe treatment for Chinese patients with moderate to severe dry eye disease.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
充电宝的应助被Hao采纳,获得10
刚刚
rmrggy完成签到,获得积分10
刚刚
zzl完成签到,获得积分20
刚刚
刚刚
未来可待完成签到,获得积分20
刚刚
路明非完成签到,获得积分10
刚刚
刚刚
keke完成签到,获得积分10
1秒前
1秒前
1秒前
感动的宛菡完成签到,获得积分10
1秒前
GHR完成签到 ,获得积分10
2秒前
aaron完成签到,获得积分10
2秒前
zzl发布了新的文献求助10
2秒前
完美世界的应助被钝角大王采纳,获得10
2秒前
csg888888完成签到,获得积分10
3秒前
Nefert完成签到,获得积分10
3秒前
rmrggy发布了新的文献求助10
3秒前
李爱国的应助被e00ec采纳,获得10
3秒前
爆米花的应助被jiashan采纳,获得10
4秒前
哈哈发布了新的文献求助10
4秒前
Simon完成签到,获得积分10
4秒前
5秒前
未来可待发布了新的文献求助20
5秒前
5秒前
资浩阑发布了新的文献求助10
6秒前
6秒前
6秒前
7秒前
温柔的依霜完成签到,获得积分10
8秒前
LouieHuang完成签到,获得积分10
8秒前
科研通AI65的应助被叫你吃布丁采纳,获得10
8秒前
8秒前
科研通AI6.3的应助被柯科研采纳,获得20
8秒前
9秒前
xuexi完成签到,获得积分10
9秒前
脑洞疼的应助被cs采纳,获得10
9秒前
10秒前
linxin完成签到,获得积分10
10秒前
资浩阑完成签到,获得积分10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181155
求助须知:如何正确求助?哪些是违规求助? 9571140
关于积分的说明 21816740
捐赠科研通 7777528
什么是DOI,文献DOI怎么找? 3433436
关于科研通互助平台的介绍 2557664
邀请新用户注册赠送积分活动 2479482